Avutometinib and Defactinib in Diffuse Gastric Cancer

NCT06487221 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Stomach Cancer

Interventions

DRUG: Avutometinib
DRUG: Defactinib

Sponsor

Ryan H. Moy, MD, PhD

Collaborators

[object Object]